EGFR and lung adenocarcinoma: As of today, this has been the first and largest clinical trial of evidence-based medicine which uses the evaluation system of integrated traditional Chinese and Western medicine to evaluate the efficacy of Chinese herbal medicine combined with chemotherapy in the treatment of lung adenocarcinoma patients with EGFR-TKIs resistance.